Inventys Research raises Rs 225 crore led by Plutus Wealth, Pantomath Capital
Plutus Wealth Management committed Rs 225 crores of primary infusion into the company. At the same time, India Inflection Opportunity Fund, managed by Pantomath Capital Management, picks up the secondary round offered by certain existing sharehold...

Plutus Wealth Management committed Rs 225 crores of primary infusion into the company. At the same time, India Inflection Opportunity Fund, managed by Pantomath Capital Management, picks up the secondary round offered by certain existing shareholders of the company.
Inventys is a research-driven specialty chemical manufacturer focusing on custom synthesis and manufacturing (CSM). The company has a diversified product portfolio comprising Advanced Intermediates & Actives used in Crop-Protection and Pharmaceutical applications and other specialty segments.
Pantomath Capital Advisors Private Limited acted as the sole investment banker for the transaction.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.